Skip to main content

Targeted radiotherapy of brain tumours.

Publication ,  Journal Article
Zalutsky, MR
Published in: Br J Cancer
April 19, 2004

The utility of external beam radiotherapy for the treatment of malignant brain tumours is compromised by the need to avoid excessive radiation damage to normal CNS tissues. This review describes the current status of targeted radiotherapy, an alternative strategy for brain tumour treatment that offers the exciting prospect of increasing the specificity of tumour cell irradiation.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Br J Cancer

DOI

ISSN

0007-0920

Publication Date

April 19, 2004

Volume

90

Issue

8

Start / End Page

1469 / 1473

Location

England

Related Subject Headings

  • Radioimmunotherapy
  • Radiation Injuries
  • Oncology & Carcinogenesis
  • Humans
  • Glioblastoma
  • Clinical Trials as Topic
  • Brain Neoplasms
  • Astrocytoma
  • Antibodies, Monoclonal
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Zalutsky, M. R. (2004). Targeted radiotherapy of brain tumours. Br J Cancer, 90(8), 1469–1473. https://doi.org/10.1038/sj.bjc.6601771
Zalutsky, M. R. “Targeted radiotherapy of brain tumours.Br J Cancer 90, no. 8 (April 19, 2004): 1469–73. https://doi.org/10.1038/sj.bjc.6601771.
Zalutsky MR. Targeted radiotherapy of brain tumours. Br J Cancer. 2004 Apr 19;90(8):1469–73.
Zalutsky, M. R. “Targeted radiotherapy of brain tumours.Br J Cancer, vol. 90, no. 8, Apr. 2004, pp. 1469–73. Pubmed, doi:10.1038/sj.bjc.6601771.
Zalutsky MR. Targeted radiotherapy of brain tumours. Br J Cancer. 2004 Apr 19;90(8):1469–1473.

Published In

Br J Cancer

DOI

ISSN

0007-0920

Publication Date

April 19, 2004

Volume

90

Issue

8

Start / End Page

1469 / 1473

Location

England

Related Subject Headings

  • Radioimmunotherapy
  • Radiation Injuries
  • Oncology & Carcinogenesis
  • Humans
  • Glioblastoma
  • Clinical Trials as Topic
  • Brain Neoplasms
  • Astrocytoma
  • Antibodies, Monoclonal
  • 3211 Oncology and carcinogenesis